drugset / Trial / NCT00796354

Constipation Associated With Irritable Bowel Syndrome (IBS-C)

NCT00796354

Phase 3 Completed 210 enrolled Norgine
RandomizedParallel-groupDouble-blindTreatment

Summary

Multi-centre, double-blind, randomised, placebo-controlled, parallel group study.

Timeline

Start
2008-11
Primary completion
2010-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator sodium chloride Unknown

Indications